Filing Details

Accession Number:
0000769993-15-001051
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-12-11 20:21:51
Reporting Period:
2015-12-09
Filing Date:
2015-12-11
Accepted Time:
2015-12-11 20:21:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492674 T2 Biosystems Inc. TTOO Surgical & Medical Instruments & Apparatus (3841) 204827488
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
769993 Goldman Sachs & Co 200 West Street
New York NY 10282
No No No No
886982 Goldman Sachs Group Inc 200 West Street
New York NY 10282
No No No No
1572490 Bridge Street 2013, L.p. 200 West Street
New York NY 10282
No No No No
1572491 Bridge Street 2013 Offshore, L.p. 200 West Street
New York NY 10282
No No No No
1572501 Mbd 2013, L.p. 200 West Street
New York NY 10282
No No No No
1572502 Mbd 2013 Offshore, L.p. 200 West Street
New York NY 10282
No No No No
1575993 Broad Street Principal Investments, L.l.c. 200 West Street
New York NY 10282
No No No No
1615636 Bridge Street Opportunity Advisors, L.l.c. 200 West Street
New York NY 10282
No No No No
1615711 Bridge Street 2013 Holdings, L.p. 200 West Street
New York NY 10282
No No No No
1615732 Mbd 2013 Holdings, L.p. 200 West Street
New York NY 10282
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-12-09 700,000 $9.75 4,157,240 No 4 P Indirect See footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnotes
Footnotes
  1. This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group"), Goldman, Sachs & Co. ("Goldman Sachs"), MBD 2013, L.P. ("MBD"), MBD 2013 Offshore, L.P. ("MBD Offshore"), MBD 2013 Holdings, L.P. ("MBD Holdings"), Broad Street Principal Investments, L.L.C. ("Broad Street"), Bridge Street 2013, L.P. ("Bridge Street"), Bridge Street 2013 Offshore, L.P. ("Bridge Street Offshore"), and Bridge Street 2013 Holdings, L.P. ("Bridge Street Holdings" and, together with MBD, MBD Offshore, MBD Holdings, Broad Street, Bridge Street, and Bridge Street Offshore, the "GS Funds"), MBD Advisors, L.L.C. ("MBD Advisors") and Bridge Street Opportunity Advisors, L.L.C. ("Bridge Street Advisors" and, together with GS Group, Goldman Sachs, the GS Funds and MBD Advisors, the "Reporting Persons").
  2. Due to the electronic system's limitation of 10 Reporting Persons per joint filing, this statement is being filed in duplicate.
  3. In connection with the closing of a follow-on public offering (the "Offering") of Common Stock, par value $0.001 per share (the "Common Stock") of T2 Biosystems, Inc. (the "Company"), which occurred on December 9, 2015, certain of the GS Funds purchased an aggregate of 700,000 shares of the Common Stock at the Offering price of $9.75. Specifically, Broad Street purchased 588,000 shares of Common Stock, Bridge Street Holdings purchased 86,800 shares of Common Stock and MBD Holdings purchased 25,200 shares of Common Stock.
  4. GS Group and Goldman Sachs may be deemed to beneficially own indirectly, in the aggregate, 4,157,240 shares of Common Stock by reason of the direct beneficial ownership of Common Stock by certain of the GS Funds because GS Group, or affiliates of GS Group and Goldman Sachs, are the general partner, managing general partner, managing partner, managing member or member of each of the GS Funds. Goldman Sachs is a wholly owned subsidiary of GS Group. Goldman Sachs is the investment manager of certain of the GS Funds.
  5. Broad Street beneficially owns directly 3,492,083 shares of Common Stock. Bridge Street Holdings beneficially owns directly 515,497 shares of Common Stock. Bridge Street, Bridge Street Offshore and Bridge Street Advisors may each be deemed to beneficially own indirectly 515,497 shares of Common Stock by reason of the direct beneficial ownership of Common Stock by Bridge Street Holdings. MBD Holdings beneficially owns directly 149,660 shares of Common Stock. MBD, MBD Offshore and MBD Advisors may each be deemed to beneficially own indirectly 149,660 shares of Common Stock by reason of the direct beneficial ownership of Common Stock by MBD Holdings.
  6. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any.